BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21106246)

  • 21. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.
    Gras S; Saulquin X; Reiser JB; Debeaupuis E; Echasserieau K; Kissenpfennig A; Legoux F; Chouquet A; Le Gorrec M; Machillot P; Neveu B; Thielens N; Malissen B; Bonneville M; Housset D
    J Immunol; 2009 Jul; 183(1):430-7. PubMed ID: 19542454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.
    Ciatto C; Tissot AC; Tschopp M; Capitani G; Pecorari F; Plückthun A; Grütter MG
    J Mol Biol; 2001 Oct; 312(5):1059-71. PubMed ID: 11580250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions.
    Cole DK; Miles KM; Madura F; Holland CJ; Schauenburg AJ; Godkin AJ; Bulek AM; Fuller A; Akpovwa HJ; Pymm PG; Liddy N; Sami M; Li Y; Rizkallah PJ; Jakobsen BK; Sewell AK
    J Biol Chem; 2014 Jan; 289(2):628-38. PubMed ID: 24196962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
    Sitaru AG; Timmermann W; Ulrichs K; Otto C
    Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
    Tynan FE; Burrows SR; Buckle AM; Clements CS; Borg NA; Miles JJ; Beddoe T; Whisstock JC; Wilce MC; Silins SL; Burrows JM; Kjer-Nielsen L; Kostenko L; Purcell AW; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Nov; 6(11):1114-22. PubMed ID: 16186824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein.
    Wiertz E; van Gaans-van den Brink J; Hoogerhout P; Poolman J
    Eur J Immunol; 1993 Jan; 23(1):232-9. PubMed ID: 7678224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling of the TCR-MHC-peptide complex.
    Michielin O; Luescher I; Karplus M
    J Mol Biol; 2000 Jul; 300(5):1205-35. PubMed ID: 10903865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the structure of the LC13 TCR/HLA-B8-EBV peptide complex with molecular dynamics simulations.
    Stavrakoudis A
    Cell Biochem Biophys; 2011 Jul; 60(3):283-95. PubMed ID: 21253892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens.
    Choi YW; Herman A; DiGiusto D; Wade T; Marrack P; Kappler J
    Nature; 1990 Aug; 346(6283):471-3. PubMed ID: 2377208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural alterations in peptide-MHC recognition by self-reactive T cell receptors.
    Wucherpfennig KW; Call MJ; Deng L; Mariuzza R
    Curr Opin Immunol; 2009 Dec; 21(6):590-5. PubMed ID: 19699075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell receptor CDR3 sequences and recombinant T cell receptors. Prerequisites for developing ligands to interfere with T cell receptor binding to the MHC/peptide complex.
    Sowka S; Friedl-Hajek R; Siemann U; Ebner C; Scheiner O; Breiteneder H
    Int Arch Allergy Immunol; 1997; 113(1-3):170-2. PubMed ID: 9130513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC.
    Sethi DK; Schubert DA; Anders AK; Heroux A; Bonsor DA; Thomas CP; Sundberg EJ; Pyrdol J; Wucherpfennig KW
    J Exp Med; 2011 Jan; 208(1):91-102. PubMed ID: 21199956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MPID-T: database for sequence-structure-function information on T-cell receptor/peptide/MHC interactions.
    Tong JC; Kong L; Tan TW; Ranganathan S
    Appl Bioinformatics; 2006; 5(2):111-4. PubMed ID: 16722775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How peptide/MHC presence affects the dynamics of the LC13 T-cell receptor.
    Dominguez JL; Knapp B
    Sci Rep; 2019 Feb; 9(1):2638. PubMed ID: 30804417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationship of T-cell receptors based on alanine scanning.
    Narimatsu S; Yoshioka Y; Morishige T; Yao X; Tsunoda S; Tsutsumi Y; Nishimura MI; Mukai Y; Okada N; Nakagawa S
    Biochem Biophys Res Commun; 2011 Dec; 415(4):558-62. PubMed ID: 22079637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes.
    Teng MK; Smolyar A; Tse AG; Liu JH; Liu J; Hussey RE; Nathenson SG; Chang HC; Reinherz EL; Wang JH
    Curr Biol; 1998 Mar; 8(7):409-12. PubMed ID: 9545202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strength of TCR-peptide/MHC interactions and in vivo T cell responses.
    Corse E; Gottschalk RA; Allison JP
    J Immunol; 2011 May; 186(9):5039-45. PubMed ID: 21505216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.